Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | 4506:TYO since announced | Transaction value |
---|---|---|
Nabriva Therapeutics PLC - Lefamulin Assets | -46.76% | 15.00m |
Data delayed at least 20 minutes, as of May 16 2024 02:37 BST.
Holder | Shares | % Held |
---|---|---|
JPMorgan Asset Management (UK) Ltd.as of 31 Dec 2022 | 1.39m | 0.35% |
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.